Medicare is offering beneficiaries access to popular obesity drugs for a $50 monthly copay. Patients have to meet certain criteria to qualify. It's a temporary measure that runs through 2027.
Copyright 2026 NPR
KPBS keeps you informed with local stories you need to know about — with no paywall. Our news is free for everyone because people like you help fund it.
Without federal funding, community support is our lifeline.
Make a gift to protect the future of KPBS.